Unichem Laboratories receives USFDA approval for Solifenacin Succinate Tablets

Unichem Laboratories has received ANDA approval from US FDA for Solifenacin Succinate Tablets, 5 mg and 1 0 mg to market a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc. which are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.

The Product will be commercialized from Unichem's Goa plant.

Powered by Capital Market - Live News